Polychromatic flow cytometry in evaluating rheumatic disease patients

• Authors: Chungwen Wei, Emory University; Scott Jenks, Emory University; Ignacio Sanz, Emory University
• Journal Title: Arthritis Research and Therapy
• Volume: Volume 17, Number 1
• Publisher: BioMed Central | 2015-03-05, Pages 46-46
• Type of Work: Article | Final Publisher PDF
• Publisher DOI: http://doi.org/10.1186/s13075-015-0561-1
• Subjects: Health Sciences, Immunology
• Keywords: Science & Technology; Life Sciences & Biomedicine; Rheumatology; MEMORY B-CELLS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY SJOGRENS-SYNDROME; PERIPHERAL-BLOOD; SYNOVIAL TISSUE; LYMPHOCYTE HOMEOSTASIS; DEPRESSED PERCENTAGE; DEPLETION THERAPY; SALIVARY-GLANDS; EARLY ARTHRITIS

Abstract

B cells are central players in multiple autoimmune rheumatic diseases as a result of the imbalance between pathogenic and protective B-cell functions, which are presumably mediated by distinct populations. Yet the functional role of different B-cell populations and the contribution of specific subsets to disease pathogenesis remain to be fully understood owing to a large extent to the use of pauci-color flow cytometry. Despite its limitations, this approach has been instrumental in providing a global picture of multiple B-cell abnormalities in multiple human rheumatic diseases, more prominently systemic lupus erythematosus, rheumatoid arthritis and Sjogren's syndrome. Accordingly, these studies represent the focus of this review. In addition, we also discuss the added value of tapping into the potential of polychromatic flow cytometry to unravel a higher level of B-cell heterogeneity, provide a more nuanced view of B-cell abnormalities in disease and create the foundation for a precise understanding of functional division of labor among the different phenotypic subsets. State-of-the-art polychromatic flow cytometry and novel multidimensional analytical approaches hold tremendous promise for our understanding of disease pathogenesis, the generation of disease biomarkers, patient stratification and personalized therapeutic approaches.